Early MS trial: Modified blood cells were well tolerated
Key Takeaway
In an early MS trial, people tolerated a treatment made from their own red blood cells, and several health measures stayed stable.
What They Found
Researchers coated participants' own red blood cells with pieces of myelin, the protective covering around nerves. Participants tolerated the treatment, and several health measures and brain scan findings stayed stable. A marker of tissue inflammation in the brain fell after treatment. Three months after one dose, immune cells that may calm harmful reactions increased, while cells linked to inflammation decreased. Studies in people and mice showed that the treated blood cells were quickly processed in the liver and spleen.
Who Should Care and Why
The treatment trial included people with MS, but the abstract does not say which form of MS they had. Researchers also studied mice to see where the treated blood cells went. The treatment used each person's own red blood cells. The trial examined health measures, brain scans, and immune cells. Its findings describe an early test of a treatment intended to change how the immune system reacts to myelin.
Important Considerations
This was an early trial in which everyone received the treatment and researchers tested increasing doses. The abstract does not give the number of participants. Without a comparison group, the trial cannot show whether the treatment caused the stable health measures or the immune changes.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/15/2026
Researchers suggest adding a drug after stem cell transplant to help keep MS from returning. Learn h
Read More
10/14/2026
Exercise may help people use less energy while walking, but evidence for MS is limited. See what thi
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Proceedings of the National Academy of Sciences of the United States of America often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.